Related Experiment Videos
[Creutzfeldt-Jakob disease and transfusional risk: the point in 1998]
1Laboratoire de virologie transfusionnelle, Institut national de la transfusion sanguine, Paris.
Insights
Creutzfeldt-Jakob disease (CJD) transmission via blood transfusion is a theoretical risk. Current measures include excluding at-risk donors and leukocyte depletion, with ongoing surveillance for new variant CJD (nvCJD).
Area of Science:
- Neuroscience
- Transfusion Medicine
- Epidemiology
Background:
- Iatrogenic and experimental transmission of Creutzfeldt-Jakob disease (CJD) are established.
- The potential for CJD transmission through blood transfusion due to contaminated blood components is a significant concern.
- Emerging research indicates a potential role for B lymphocytes in CJD pathogenesis.
Purpose of the Study:
- To assess the risk of CJD transmission via blood transfusion.
- To review current strategies for mitigating transfusion-related CJD.
- To highlight the importance of surveillance for new variant CJD (nvCJD).
Main Methods:
- Review of existing epidemiological and experimental data on CJD transmission.
- Analysis of the role of B lymphocytes in CJD.
- Evaluation of current blood safety measures, including donor exclusion and leukocyte depletion.
Main Results:
- No definitive epidemiological evidence currently links classical CJD transmission to B lymphocytes.
- Theoretical risk of transfusion-transmitted CJD persists.
- New variant CJD (nvCJD) shows tropism for lymphoreticular tissues, necessitating vigilance.
Conclusions:
- Exclusion of at-risk blood donors and leukocyte depletion are key preventive measures against transfusion-transmitted CJD.
- Continued surveillance for nvCJD is crucial due to its association with lymphoreticular tissues.
- The absence of a biological marker for CJD underscores the importance of these precautionary strategies.
Abstract:
As both iatrogenic and experimental transmission of Creutzfeldt-Jakob disease (CJD) have been demonstrated, potential blood transfusion-related CJD through blood component contamination is not unlikely. Recent studies also suggest that B lymphocytes would play a crucial role in the disease pathogenesis. However, to date, there is no epidemiological evidence suggesting that classical transmission of CJD would involve B lymphocytes. To reduce the theoretical risk of such transmission and as no biological marker of the disease is currently available, at-risk blood donors are excluded and leukocyte depletion has been introduced. Furthermore, the recent discovery of a new variant of the disease (nwCJD) which is caused by the bovine agent and has typical tropism for lymphoreticular tissues should lead to close surveillance.